CONTACT US
INTERNATIONAL
INVESTORS
CAREERS
FIND A PROVIDER

Blog

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, […]

Report on Inner Arm excess skin relaxation treatment through Dermoelectroporation

Dr. A.Gessati*, *Aesthetic medicine Doctor, Milan, Italy.   Preliminary Study Dermoelectroporation, well known and established method for transdermal substances delivery without the use of needles, allows to get to important results for skin imperfection conditions, such as the inner arm areas relaxation (with the formation of bands of tissue in excess), which are often solved […]

Report on Hyaluronic Acid & Oligopeptides cocktail treatments through Dermoelectroporation

Dr. James Fulton, vivant Skin Care , Miami Florida, USA   Preliminary Study To evaluate the safety, tolerability and effectiveness of transdermal delivery of a Hyaluronic Acid & Oligopeptides cocktail for either facial lifting and finelines reduction purposes through Dermoelectroporation®. Study Design Delivered every 1 or 2 weeks for a total of 8 treatments. Oligopeptides […]

Report on Actinic Keratosis reduction treatment through Dermoelectroporation

Dr. Gabriela Vasilescu, M.D. Vascular Surgery Specialist, Martelli clinic, via del Bersaglio, 7 – Florence, Italy   Through Dermoelectroporation, the one and most innovative method for transdermal delivery of water based active ingredients into the body without needles, very important results have been achieved when fighting skin imperfections, elder and actinic keratosis normally cancelled using […]

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales BOCA RATON, Fla, Jan. 31, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General […]

Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022

BOCA RATON, Fla, Jan. 26, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 10, 2022 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter […]

Keloid Scar Removal Near Me: What is It?

Keloids are a mystery for most people. The average person doesn’t know what they are and why they exist. It’s estimated that 10% of people have at least one keloid. Some keloids are small and unnoticeable. Others are large and obvious in places other people can see them. If you are wondering “where can I […]

Sensus Healthcare to Present at the H.C. Wainwright BioConnect Virtual Conference

Company Management Available for 1×1 Meetings Concurrent with the 40th Annual J.P. Morgan Healthcare Conference January 10-14 BOCA RATON, Fla. , Jan. 06, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that Joe Sardano, chairman and chief […]

Sensus Healthcare Expects Record 4Q 2021 Sales and Continued Growth in 1Q 2022; Profiles New Product at the 2022 Winter Clinical Dermatology Conference

Expects profitability for the 2021 fourth quarter and full year Physician KOL presentation at the Winter Clinical to highlight the TransDermal Infusion System™ BOCA RATON, Fla., Jan. 05, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that […]

The Alternative Skin Cancer Treatment

If you’ve been diagnosed with skin cancer, you might be wondering what your options are when it comes to your treatment. For nearly 90 years, Mohs surgery has been the procedure of choice to treat skin cancer. But there is now an alternative skin cancer treatment. Sensus Healthcare’s line of SRT devices utilizes Superficial Radio […]

The Dermatology Digest – Superficial Radio Therapy Clinical Benefits and Studies

Not all treatment modalities for non-melanoma skin cancer are the same. In Part 2 of this video series, Dr. Mark Nestor discusses studies that demonstrate the clinical benefits of SRT, including cure rate, cosmesis, and consensus guidelines. About This Series In this 3-part educational series, Dr. Mark Nestor reviews the core concepts and treatment modalities […]

Sensus Healthcare Signs Exclusive U.S. Distribution Agreement with Mattioli Eng. Italia for its TransDermal Infusion System

Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning [Immediately/Date] BOCA RATON, Fla, Dec. 01, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the signing of an exclusive U.S. distribution agreement […]

Treatment for Squamous Cell Carcinoma

Squamous cell carcinoma is a common form of skin cancer that develops in the squamous cells that make up the middle and outer layers of the skin. Though usually not life-threatening, this cancer can be aggressive. If left untreated, squamous cell carcinoma can grow large and spread to other parts of the body, causing serious […]